HAEM5:Myeloid sarcoma: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) Removed old template contents |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Myeloid sarcoma}} | {{DISPLAYTITLE:Myeloid sarcoma}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 14: | Line 13: | ||
Yalda Naeini, MD, School of Medicine at University of California Los Angeles | Yalda Naeini, MD, School of Medicine at University of California Los Angeles | ||
Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||